NextCure, Inc

(NASDAQ:NXTC)

Latest On NextCure, Inc (NXTC):

Date/Time Type Description Signal Details
2023-05-05 03:59 ESTNewsNextCure GAAP EPS of -$0.58 beats by $0.04N/A
2023-03-02 20:07 ESTNewsNextCure GAAP EPS of -$2.69 misses by $0.04N/A
2022-11-15 23:06 ESTNewsNextCure, South Korea's LegoChem Biosciences to develop antibody drug conjugatesN/A
2022-11-04 06:27 ESTNewsNextCure GAAP EPS of -$0.68 misses by $0.02N/A
2022-08-05 06:10 ESTNewsNextCure GAAP EPS of -$0.65 beats by $0.09N/A
2022-06-16 05:41 ESTNewsNextCure (NXTC) Investor Presentation - SlideshowN/A
2022-05-06 06:02 ESTNewsNextCure GAAP EPS of -$0.74 misses by $0.07N/A
2022-03-04 09:13 ESTNewsNextCure GAAP EPS of -$2.51N/A
2022-02-26 07:06 ESTNewsNextCure (NXTC) Presents At Global Healthcare Virtual Conference - SlideshowN/A
2021-11-05 11:05 ESTNewsNextCure EPS beats by $0.02N/A
2021-09-29 20:40 ESTNewsNextCure: Large Upside With Downside Protected By Cash PileN/A
2021-09-22 02:30 ESTNewsNextCure (NXTC) Presents At H. C. Wainwright 23rd Annual Global Investment Conference - SlideshowN/A
2021-09-11 01:54 ESTNewsNextCure (NXTC) Presents At The 19th Annual Morgan Stanley Virtual Global Healthcare Conference - SlideshowN/A
2021-08-06 08:09 ESTNewsNextCure EPS misses by $0.04N/A
2021-05-07 13:04 ESTNewsNextCure EPS misses by $0.01N/A
2021-04-15 23:56 ESTNewsNextCure (NXTC) Presents At 20th Annual Needham Healthcare Conference - SlideshowN/A
2021-03-16 21:37 ESTAnalyst RatingThe Analyst Target Price has decreased from $23.33 to $19.38.Neutral
2021-03-08 08:21 ESTAnalyst RatingThe Analyst Target Price has increased from $22.67 to $23.33.Buy
2021-03-06 00:05 ESTNewsNextCure raised to buy at Truist after R&D eventN/A
2021-03-05 20:23 ESTFinancialsCompany financials have been released.Neutral
2021-03-05 12:07 ESTAnalyst RatingThe Analyst Target Price has decreased from $23.33 to $22.67.Neutral
2021-03-05 12:07 ESTEarnings EstimateAn EPS average of -$2.89 is estimated for the 2022 year.Sell
2021-03-05 12:07 ESTEarnings EstimateAn EPS average of -$0.65 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-05 02:41 ESTNewsNextCure EPS beats by $0.01, revenue in-lineN/A
2021-01-18 08:12 ESTAnalyst RatingThe Analyst Target Price has decreased from $23.67 to $23.33.Neutral
2021-01-14 23:30 ESTNewsNextCure appoints new chief medical officerN/A
2020-12-17 21:49 ESTNewsNextCure provides update on NC318 clinical programN/A
2020-11-26 21:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 20:40 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 12:53 ESTEarnings EstimateAn EPS average of -$0.59 is estimated for the quarter ending on March 31, 2021.N/A
2020-11-08 00:24 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:41 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 13:50 ESTNewsNextCure EPS misses by $0.02N/A
2020-09-26 13:36 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:42 ESTFinancialsCompany financials have been released.Neutral
2020-08-25 16:11 ESTNewsWhat's Next For NextCureN/A
2020-08-14 09:40 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 05:27 ESTAnalyst RatingThe Analyst Target Price has decreased from $25.89 to $23.67.Neutral
2020-08-09 13:23 ESTFinancialsCompany financials have been released.Neutral
2020-08-08 00:19 ESTNewsMixed shelf roundup - healthcareN/A
2020-08-07 17:26 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 23:30 ESTNewsNextCure EPS misses by $0.03N/A
2020-08-06 21:29 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 13:25 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 01:52 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 17:22 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 05:21 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 13:17 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 17:57 ESTFinancialsCompany financials have been released.Neutral
2020-07-20 17:26 ESTAnalyst RatingThe Analyst Target Price has decreased from $65.88 to $25.89.Neutral

About NextCure, Inc (NXTC):

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; and NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. NextCure, Inc. has a license agreement with Yale University. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.

NXTC Quotes by TradingView

See Advanced Chart

General

  • Name NextCure, Inc
  • Symbol NXTC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 90
  • Fiscal Year EndDecember
  • IPO Date2019-05-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.nextcure.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 14.64
  • Price/Book (Most Recent Quarter) 1.12
  • Enterprise Value Revenue 2.17
  • Enterprise Value EBITDA 0.18
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.51
  • Next Year EPS Estimate -$2.79
  • Next Quarter EPS Estimate -$0.62
  • Profit Margin -164%
  • Operating Margin -184%
  • Return on Assets -8%
  • Return on Equity -12%
  • Revenue 22.38 million
  • Earnings Per Share -$1.92
  • Revenue Per Share $0.81
  • Gross Profit -24176000
  • Quarterly Earnings Growth -100%
View More

Highlights

  • Market Capitalization 336.17 million
  • EBITDA -26598000
  • Analyst Target Price $19.38
  • Book Value Per Share $10.65
View More

Share Statistics

  • Shares Outstanding 27.6 million
  • Shares Float 19.54 million
  • % Held by Insiders 1433%
  • % Held by Institutions 74.9%
  • Shares Short 1.58 million
  • Shares Short Prior Month 1.94 million
  • Short Ratio 7.27
  • Short % of Float 6%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • 52 Week High $40.94
  • 52 Week Low $7.91
  • 50 Day Moving Average 12.32
  • 200 Day Moving Average 11.03
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

NextCure, Inc (NXTC) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

NextCure, Inc (NXTC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-04$N/A-$0.54-$0.609.67%
2020-09-302020-11-05$N/A-$0.59-$0.57-4.19%
2020-06-302020-08-06$N/A-$0.53-$0.50-5.31%
2020-03-312020-05-07$N/A$0.33-$0.44174.51%
2019-12-312020-03-12$2.01 million-$0.34-$0.4525.16%
2019-09-302019-11-12$1.58 million-$0.37-$0.35-5.71%
2019-06-302019-08-12$1.4 million-$0.61-$0.47-31.18%
2019-03-312019-05-09$1.36 million-$4.46-$0.53-741.51%

NextCure, Inc (NXTC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

NextCure, Inc (NXTC) Chart:

NextCure, Inc (NXTC) News:

Below you will find a list of latest news for NextCure, Inc (NXTC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

NextCure, Inc (NXTC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-162.50.05CALL0 1459.69FALSE00
2025-05-1650CALL0 00FALSE00
2025-05-167.50CALL0 00FALSE00
2025-05-162.50PUT0 00TRUE00
2025-05-1650PUT0 00TRUE00
2025-05-167.50PUT0 00TRUE00
2025-06-202.50.1CALL0 15285.17FALSE00
2025-06-2050CALL0 00FALSE00
2025-06-207.50.15CALL0 10FALSE00
2025-06-202.50PUT0 00TRUE00
2025-06-2050PUT0 00TRUE00
2025-06-207.50PUT0 00TRUE00
2025-09-192.50.05CALL1 20209.48FALSE0.050
2025-09-1950.05CALL0 1217.41FALSE00
2025-09-197.50CALL0 00FALSE00
2025-09-192.50PUT0 0466.23TRUE00
2025-09-1950PUT0 00TRUE00
2025-09-197.50PUT0 00TRUE00
2025-12-192.50CALL0 0164.32FALSE00
2025-12-1950CALL0 00FALSE00
2025-12-197.50CALL0 00FALSE00
2025-12-192.50PUT0 00TRUE00
2025-12-1950PUT0 00TRUE00
2025-12-197.50PUT0 00TRUE00

Latest NXTC Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST200$4.645
Jun 13, 2022 7:58 PM EST300$4.645
Jun 13, 2022 7:59 PM EST9$4.645
Jun 13, 2022 7:59 PM EST100$4.63
Jun 13, 2022 7:59 PM EST13$4.64

NextCure, Inc (NXTC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000885/0001123292-20-000885-index.htm
2019-02-25UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661059/000000000019003113/0000000000-19-003113-index.htm
2019-03-13UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661059/000000000019004619/0000000000-19-004619-index.htm
2019-11-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661059/000000000019015264/0000000000-19-015264-index.htm
2019-05-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661059/000007800319000029/0000078003-19-000029-index.htm
2020-10-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661059/000089542120000516/0000895421-20-000516-index.htm
2019-01-30DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1661059/000091205719000030/0000912057-19-000030-index.htm
2019-03-05DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1661059/000091205719000071/0000912057-19-000071-index.htm
2019-04-01DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1661059/000091205719000136/0000912057-19-000136-index.htm
2019-10-30DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1661059/000091205719000425/0000912057-19-000425-index.htm
2019-11-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661059/000092963819001005/0000929638-19-001005-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661059/000092963820000330/0000929638-20-000330-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661059/000093041320000375/0000930413-20-000375-index.htm
2019-05-21SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661059/000094787119000387/0000947871-19-000387-index.htm
2019-11-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661059/000094787119000830/0000947871-19-000830-index.htm
2019-04-12S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661059/000104746919002203/0001047469-19-002203-index.htm
2019-04-29S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661059/000104746919002652/0001047469-19-002652-index.htm
2019-05-03S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661059/000104746919002857/0001047469-19-002857-index.htm
2019-05-08S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661059/000104746919002935/0001047469-19-002935-index.htm
2019-05-09424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1661059/000104746919002988/0001047469-19-002988-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661059/000104746919003060/0001047469-19-003060-index.htm
2019-11-12S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661059/000104746919006237/0001047469-19-006237-index.htm
2019-11-14S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661059/000104746919006303/0001047469-19-006303-index.htm
2019-11-18424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1661059/000104746919006335/0001047469-19-006335-index.htm
2020-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1661059/000104746920002583/0001047469-20-002583-index.htm
2019-04-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661059/000110465919021960/0001104659-19-021960-index.htm
2019-05-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661059/000110465919027155/0001104659-19-027155-index.htm
2019-05-088-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1661059/000110465919027670/0001104659-19-027670-index.htm
2019-05-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1661059/000110465919029015/0001104659-19-029015-index.htm
2019-05-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1661059/000110465919029017/0001104659-19-029017-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661059/000110465919045001/0001104659-19-045001-index.htm
2019-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661059/000110465919052393/0001104659-19-052393-index.htm
2019-11-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661059/000110465919062669/0001104659-19-062669-index.htm
2019-11-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661059/000110465919062672/0001104659-19-062672-index.htm
2019-11-14S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1661059/000110465919064433/0001104659-19-064433-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000110465919065582/0001104659-19-065582-index.htm
2019-11-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661059/000110465919066346/0001104659-19-066346-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661059/000110465919068982/0001104659-19-068982-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661059/000110465920003214/0001104659-20-003214-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661059/000110465920021710/0001104659-20-021710-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661059/000110465920039889/0001104659-20-039889-index.htm
2020-04-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1661059/000110465920051303/0001104659-20-051303-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661059/000110465920072403/0001104659-20-072403-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661059/000110465920083106/0001104659-20-083106-index.htm
2020-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661059/000110465920084546/0001104659-20-084546-index.htm
2020-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661059/000110465920089093/0001104659-20-089093-index.htm
2020-08-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1661059/000110465920091521/0001104659-20-091521-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661059/000110465920104856/0001104659-20-104856-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000721/0001123292-19-000721-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000722/0001123292-19-000722-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000723/0001123292-19-000723-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000724/0001123292-19-000724-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000725/0001123292-19-000725-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000726/0001123292-19-000726-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000727/0001123292-19-000727-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000728/0001123292-19-000728-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000729/0001123292-19-000729-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000730/0001123292-19-000730-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000731/0001123292-19-000731-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000732/0001123292-19-000732-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000733/0001123292-19-000733-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000734/0001123292-19-000734-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000735/0001123292-19-000735-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000736/0001123292-19-000736-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000737/0001123292-19-000737-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000748/0001123292-19-000748-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000749/0001123292-19-000749-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000750/0001123292-19-000750-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000751/0001123292-19-000751-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000752/0001123292-19-000752-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000886/0001123292-19-000886-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000887/0001123292-19-000887-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000888/0001123292-19-000888-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000889/0001123292-19-000889-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000890/0001123292-19-000890-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000891/0001123292-19-000891-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000892/0001123292-19-000892-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329219000893/0001123292-19-000893-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000301/0001123292-20-000301-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000457/0001123292-20-000457-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000458/0001123292-20-000458-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000459/0001123292-20-000459-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000460/0001123292-20-000460-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000461/0001123292-20-000461-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000462/0001123292-20-000462-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000463/0001123292-20-000463-index.htm
2020-04-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000634/0001123292-20-000634-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000663/0001123292-20-000663-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000878/0001123292-20-000878-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000879/0001123292-20-000879-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000880/0001123292-20-000880-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000881/0001123292-20-000881-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000882/0001123292-20-000882-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000883/0001123292-20-000883-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000884/0001123292-20-000884-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000885/0001123292-20-000885-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220000983/0001123292-20-000983-index.htm
2020-09-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220001085/0001123292-20-001085-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000112329220001087/0001123292-20-001087-index.htm
2016-01-11DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000114036116047469/0001140361-16-047469-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000114420419024597/0001144204-19-024597-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000114420419026681/0001144204-19-026681-index.htm
2019-05-17SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661059/000114420419026919/0001144204-19-026919-index.htm
2019-05-17SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661059/000114420419026954/0001144204-19-026954-index.htm
2020-02-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661059/000117266120000940/0001172661-20-000940-index.htm
2020-02-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661059/000119312520026457/0001193125-20-026457-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661059/000121390020003681/0001213900-20-003681-index.htm
2019-05-08CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1661059/000135445719000262/0001354457-19-000262-index.htm
2019-01-30DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1661059/000141057819000043/0001410578-19-000043-index.htm
2019-03-05DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1661059/000141057819000117/0001410578-19-000117-index.htm
2019-04-01DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1661059/000141057819000168/0001410578-19-000168-index.htm
2019-06-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661059/000155837019005589/0001558370-19-005589-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661059/000155837019007974/0001558370-19-007974-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661059/000155837019010701/0001558370-19-010701-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1661059/000155837020002566/0001558370-20-002566-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661059/000155837020005800/0001558370-20-005800-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661059/000155837020009660/0001558370-20-009660-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661059/000155837020012866/0001558370-20-012866-index.htm
2018-11-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000156761918006604/0001567619-18-006604-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000172202419000006/0001722024-19-000006-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661059/000172202419000008/0001722024-19-000008-index.htm
2019-05-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661059/999999999519001046/9999999995-19-001046-index.htm
2019-11-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661059/999999999519002590/9999999995-19-002590-index.htm
2019-04-29SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1661059/999999999719003597/9999999997-19-003597-index.htm
2019-05-07SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1661059/999999999719003992/9999999997-19-003992-index.htm
2020-02-10SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1661059/999999999720000621/9999999997-20-000621-index.htm
2020-02-19SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1661059/999999999720000806/9999999997-20-000806-index.htm

NextCure, Inc (NXTC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of NextCure, Inc (NXTC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1433%
Institutional Ownership: 7490%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-13Stella XuDirectorBuy125,000.0015.001,875,000.001,103,570.00https://www.sec.gov/Archives/edgar/data/1661059/000112329219000750/0001123292-19-000750-index.htm
2019-05-13TIMOTHY M SHANNONDirectorBuy50,000.0015.00750,000.002,254,442.00https://www.sec.gov/Archives/edgar/data/1661059/000112329219000752/0001123292-19-000752-index.htm
2019-05-13X L.P. CANAAN10% Share HolderBuy50,000.0015.00750,000.002,254,442.00https://www.sec.gov/Archives/edgar/data/1661059/000112329219000749/0001123292-19-000749-index.htm
2019-05-13Sofinnova Venture Partners IX, L.P.10% Share HolderBuy400,000.0015.006,000,000.002,521,856.00https://www.sec.gov/Archives/edgar/data/1661059/000114420419026681/0001144204-19-026681-index.htm
2019-11-15Sofinnova Venture Partners IX, L.P.10% Share HolderBuy150,000.0036.755,512,500.002,671,856.00https://www.sec.gov/Archives/edgar/data/1661059/000110465919065582/0001104659-19-065582-index.htm
2019-05-13Chau Quang KhuongDirectorBuy350,000.0015.005,250,000.002,711,013.00https://www.sec.gov/Archives/edgar/data/1661059/000112329219000751/0001123292-19-000751-index.htm
2019-05-13ORBIMED ADVISORS LLCDirectorBuy350,000.0015.005,250,000.002,711,013.00https://www.sec.gov/Archives/edgar/data/1661059/000112329219000748/0001123292-19-000748-index.htm
2019-11-27Linda LiuSVP, ResearchBuy34,489.000.4816,554.7234,489.00https://www.sec.gov/Archives/edgar/data/1661059/000112329220000301/0001123292-20-000301-index.htm
2020-07-14Kevin N. HellerChief Medical OfficerBuy27,229.001.7748,195.3349,011.00https://www.sec.gov/Archives/edgar/data/1661059/000112329220000983/0001123292-20-000983-index.htm
2019-11-27Linda LiuSVP, ResearchBuy20,745.001.2125,101.4555,234.00https://www.sec.gov/Archives/edgar/data/1661059/000112329220000301/0001123292-20-000301-index.htm